Public views on gene editing and its uses

  • George Gaskell (Creator)
  • Imre Bard (Creator)
  • Agnes Allansdottir (Creator)
  • Rui Vieira da Cunha (Creator)
  • Peter Eduard (Creator)
  • Juergen Hampel (Creator)
  • Elisabeth Hildt (Creator)
  • Christian Hofmaier (Creator)
  • Nicole Kronberger (Creator)
  • Sheena Laursen (Creator)
  • Anna Meijknecht (Creator)
  • Salvor Nordal (Creator)
  • Alexandre Quintanilha (Creator)
  • Gema Revuelta (Creator)
  • Núria Saladié (Creator)
  • Judit Sandor (Creator)
  • Júlio Borlido Santos (Creator)
  • Simone Seyringer (Creator)
  • Ilina Singh (Creator)
  • Han Somsen (Creator)
  • Vincent Torre (Creator)
  • Márton Varju (Creator)
  • Hub Zwart (Creator)

Dataset

Description

Rapid advances in genome editing, including CRISPR-Cas9 endonucleases, and their potential application in medicine and enhancement have been hotly debated by scientists and ethicists. Although a veto on germ line gene editing has been proposed1, the use of gene editing on human cells in the clinical context remains controversial, particularly for interventions aimed at enhancement2. In a report on human genome editing the US National Academy of Sciences (NAS) note that “important questions raised with respect to genome editing include how to incorporate societal values into salient clinical and policy consideration”3. We report here our research that opens a window onto what the public think.
Date made available9 Nov 2017
PublisherZENODO
  • Public views on gene editing and its uses

    Gaskell, G., Bard, I., Allansdottir, A., Da Cunha, R. V., Eduard, P., Hampel, J., Hildt, E., Hofmaier, C., Kronberger, N., Laursen, S., Meijknecht, A., Nordal, S., Quintanilha, A., Revuelta, G., Saladié, N., Sándor, J., Santos, J. B., Seyringer, S., Singh, I. & Somsen, H. & 5 others, Toonders, W., Torgersen, H., Torre, V., Varju, M. & Zwart, H., 9 Nov 2017, In: Nature Biotechnology. 35, 11, p. 1022-1023 2 p.

    Research output: Contribution to journalLetterpeer-review

Cite this